A systematic review to assess adherence and persistence with statins
Authors:
- 20 January 2017
- journal article
- review article
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 33 (4) , 769-778
Abstract
Objective: To identify and assess studies published over a 10 year period up to February 2016 which measure adherence or persistence with statins, to summarize their methods, strengths and weaknesses and to summarize evidence linking statin adherence/persistence with risk of cardiovascular events. Methods: Electronic databases and abstracts from four major cardiovascular disease conferences were searched from January 2005 to February 2016. The study selection process was performed by two reviewers working independently. Studies were included if they reported data regarding patient adherence or persistence with statins in adults with primary hypercholesterolemia, using any type of study design or length of follow-up. One reviewer extracted the study data and assessed study quality, which was checked by a second reviewer independently. Given the heterogeneity between the included studies a narrative critique and summary is presented. Results: We report on 84 real world studies which aimed to assess adherence or persistence with statins. The majority of studies concluded that good adherence/persistence was associated with reduction in cardiovascular events and mortality. In two studies high intensity statin regimens were associated with poorer patient adherence when compared to low intensity statins. Adherence and persistence with statin therapy also has an impact on hospitalization costs and other cardiovascular disease (CVD) related costs. Conclusions: Adherence and persistence are associated with a reduction in CVD events and mortality. There was limited evidence to suggest that high intensity statin regimens are associated with poorer treatment adherence when compared to lower intensity regimens. Hence, more robust studies are required to establish this association. As recommended by the 2013 ACC/AHA, 2016 ESC and several other clinical guidelines, clinicians and pharmacy managers should regularly monitor statin therapy adherence.Keywords
This publication has 70 references indexed in Scilit:
- Discontinuation of statin therapy due to muscular side effects: A survey in real lifeNutrition, Metabolism and Cardiovascular Diseases, 2013
- Publication bias: what is it? How do we measure it? How do we avoid it?Open Access Journal of Clinical Trials, 2013
- Association Between Statin Adherence and Cholesterol Level Reduction from Baseline in a Veteran PopulationPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
- Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort studyBMC Cardiovascular Disorders, 2011
- Statin adherence and the risk of major coronary events in patients with diabetes: a nested case–control studyBritish Journal of Clinical Pharmacology, 2010
- Long-term persistence with statin treatment in a not-for-profit health maintenance organization: A population-based retrospective cohort study in IsraelClinical Therapeutics, 2008
- Long‐term adherence to statin treatment in diabetesDiabetic Medicine, 2008
- Adherence to statin or aspirin or both in patients with established cardiovascular disease: exploring healthy behaviour vs. drug effects and 10‐year follow‐up of outcomeBritish Journal of Clinical Pharmacology, 2008
- Medication Compliance and Persistence: Terminology and DefinitionsValue in Health, 2008
- Impact of adherence to statins on coronary artery disease in primary preventionBritish Journal of Clinical Pharmacology, 2007